Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Option and Sells Shares Under 10b5-1 Plan

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 12, 2025, Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., executed stock options to acquire 67,687 shares of Class A Common Stock at an exercise price of $0.40.
• Simultaneously, Baird sold a total of 67,687 shares in multiple transactions at weighted average prices ranging from $43.3713 to $46.2681.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on May 30, 2024.
• Following these transactions, Baird directly owns 706,872 shares of Class A Common Stock and holds options for 122,243 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock option exercises and sales under a pre-arranged plan, which is a common practice.

Industry Context

This filing is a routine disclosure of insider transactions. It is common for executives to utilize 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The market will likely interpret this as a standard executive compensation activity.

Comparison to Industry Standards

• Executive stock option exercises and sales are common across publicly traded companies, particularly in the tech and healthcare sectors.
• The use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations.
• Comparable companies like Teladoc Health or GoodRx also see regular Form 4 filings from their executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increase in the number of shares available in the market.
• The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates